Gastroenterology Nurse Practice Volume 2, Issue 2 - IBD

This activity has been designed to meet the educational needs of nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate.

Learning Objectives

1. List common short-term, intermediate, and long-term treatment goals in the treatment of patients with inflammatory bowel disease (IBD)
2. Identify drug classes that have been approved by the U.S. Food and Drug Administration for the treatment of IBD
3. Assess the clinical implications of key recommendations published by expert IBD consortiums
4. Discuss the importance of shared decision making in the management of IBD

Continuing education: The Society of Gastroenterology Nurses and Associates, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation

According to the American Board of Certification for Gastroenterology Nurses (ABCGN), 1.15 hours earned in this activity is considered approved (GI Specific).

Contact hour(s): 1.15 Category 5 Contact Hours

Contact hour(s) expiration: November 18, 2025

SGNA is provider-approved by the California Board of Registered Nursing, Provider Number CEP 11579. Check with your state board of nursing for acceptability of education sessions for re-licensure.